Welcome Guest
Sign In
Register
Products
Popular Categories
Antibody Search
ELISA Kit Search
Biomolecules
Flow Cytometers
Thermal Cyclers
Microscopes
Transfection Reagents
Featured Products
New Products
Articles
Resources
eBooks
Bench Tips
Tech Insights
Editorial Articles
News
Product Reviews
Future Lab
Multimedia
Biocompare Webinars
Immunotherapy
Reproducibility
Transformative Technologies
Podcasts
Tech Talks
Bench Tip Videos
All Videos and Webinars
Life Science Webinars
Write a Review
Antibodies
Kits/Reagents
Equipment
Services
Resources
Promotions
Events
AACR SPOTLIGHT
Register
Sign In
Biocompare
Products
Protein Biochemistry
Chemicals and Reagents
UNC0638
UNC0638 from Cayman Chemical
Be the first to write a review!
Citations:
(4)
Supplier Page
Supplier Page from
Cayman Chemical for
UNC0638
Request Info
Description
A potent, selective G9a and GLP HMTase inhibitor (IC50s = MB231 cells (IC50 = 81 nM) and demonstrates favorable separation of functional and toxic effects
Product Specs
Company Info
Citations
Reviews
Product Specs
Item
UNC0638
Company
Cayman Chemical
Price
Pricing Info
Supplier Page
View Company Product Page
Catalog Number
10734
Quantity
10 mg
Research Area
Cancer, Epigenetics, Transcription, & Translation, Histone Methylation, Writers
Format
A crystalline solid
Molecular Weight
509.7
Purity
≥98%
Add to Compare List
Cayman Chemical
Cayman Chemical Company 1180 East Ellsworth Road
Ann Arbor
,
Michigan
48108
United States
Phone
: (800) 364-9897
(734) 971-3640
Company Profile
Website:
http://www.caymanchem.com/
Citations (4)
(1)
H3K9 methylation drives resistance to androgen receptor–antagonist therapy in prostate cancer
Proceedings of the National Academy of Sciences
May 24, 2022
Mehdi Baratchian et al.
(Medivation) in media supplemented with 10 nM DHEA. The EHMT1/2
inhibitor
,
UNC0638
(
Cayman
, Cat. No.
10734
) and SUV39H1
inhibitor
, F5446 (Aobious, Cat. No. AOB17639) were used for treating the EnzR cells. Xenograft
(2)
Druggable epigenetic suppression of interferon-induced chemokine expression linked to
MYCN
amplification in neuroblastoma
Journal for ImmunoTherapy of Cancer
May 20, 2021
Johanna A Seier et al.
before treatment to adhere at 60%–70% confluency. Either EHMT
inhibitor
UNC-0638 (
Cayman Chemical
, #
10734
) or
BIX-01294
(
AdipoGen, #AG
-CR1-0051) were added to the culture media at concentrations of 1 µM–5 µM.
(3)
Gain-of-Function Genetic Alterations of G9a Drive Oncogenesis
Cancer Discovery
July 1, 2020
Shinichiro Kato et al.
with 1% penicillin/streptomycin/
L-glutamine
and 10% FBS.
UNC0638
was purchased from
Cayman Chemical
(#
10734
) and reconstituted with DMSO.
UNC0642
was provided from Dr. Jian Jin for in vivo experiments.
Bafilomycin A1
(4)
Transcriptional repressor REST drives lineage stage–specific chromatin compaction at
Ptch1
and increases AKT activation in a mouse model of medulloblastoma
Science Signaling
January 24, 2019
Tara H. W. Dobson et al.
inhibitor MS275 (
Cayman
Chemicals, catalog #
13284
) and G9a
inhibitor
UNC0638
(
Cayman
Chemicals, catalog #
10734
), either alone or in combination for the time period indicated in the figures. After
labeling
with 3-(4,5-Dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium
<<
<
>
>>
Reviews
Be the First to Write a Review!
UNC0638 from Cayman Chemical
Supplier Page
View Company Product Page
Pricing Info
Product Specs
Company Info
Citations
Reviews
Back To Top